These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5643747)

  • 21. Pharmaceutical expenditure and therapeutic value of new medicines in Spain.
    Darba J
    Pharmacoeconomics; 2003; 21(16):1211-2. PubMed ID: 14594440
    [No Abstract]   [Full Text] [Related]  

  • 22. The Federal Council meeting.
    Med J Aust; 1970 Apr; 1(15):741-2. PubMed ID: 5430464
    [No Abstract]   [Full Text] [Related]  

  • 23. [Developmental trends in the health policies of the Federal Republic].
    Beske F
    Zahnarztl Mitt; 1973 Sep; 63(18):864-70. PubMed ID: 4518965
    [No Abstract]   [Full Text] [Related]  

  • 24. Should NHS patients be allowed to pay extra for their care? Debate is essential, not futile.
    Thornton H
    BMJ; 2002 Jan; 324(7329):110. PubMed ID: 11808518
    [No Abstract]   [Full Text] [Related]  

  • 25. Register-based indicators for potentially inappropriate medication in high-cost patients with excessive polypharmacy.
    Saastamoinen LK; Verho J
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):610-8. PubMed ID: 25728165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should NHS patients be allowed to pay extra for their care? Pragmatism should rule, not policy committees.
    Osborne R
    BMJ; 2002 Jan; 324(7329):110. PubMed ID: 11808519
    [No Abstract]   [Full Text] [Related]  

  • 27. Prescription charges and tuberculosis.
    Gifford JH
    Br Med J; 1968 May; 2(5600):304. PubMed ID: 5646561
    [No Abstract]   [Full Text] [Related]  

  • 28. British general practice and the National Health Service.
    Kelley PW
    Va Med; 1978 Sep; 105(9):641-3. PubMed ID: 706650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmaceutical services at the beginning of the 19th century with reference to 1815 fees of Bern drugs].
    Ledermann F
    Gesnerus; 1996; 53(1-2):34-48. PubMed ID: 8767819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Information in pharmacy. 2. Information need in pharmacy].
    Schubert M; Rogowski K
    Pharm Prax; 1972; 4():Suppl 4:73-83. PubMed ID: 5053044
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial. 'An English compromise'.
    Eur J Cancer Care (Engl); 2009 Jan; 18(1):1-2. PubMed ID: 19473219
    [No Abstract]   [Full Text] [Related]  

  • 32. Supporting Cost Effective Innovations in Treatment.
    Read C
    Health Serv J; 2017 Feb; 127(6505):16-7. PubMed ID: 30091874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polypharmacy: its cost burden and barrier to medical care in a drug-oriented health care system.
    Isenalumhe AE; Oviawe O
    Int J Health Serv; 1988; 18(2):335-42. PubMed ID: 3132431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Charging for hospital pharmaceutical services: product cost, per diem fees and fees for special clinical services.
    Smith WE; Weiblen JW
    Am J Hosp Pharm; 1979 Mar; 36(3):355-9. PubMed ID: 420228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry.
    Barros PP
    Health Econ; 2011 Apr; 20(4):461-70. PubMed ID: 21394816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The problem of unreasonably high pharmaceutical fees for patients in Chinese hospitals: a system dynamics simulation model.
    Li M; Zhu Y; Xue C; Liu Y; Zhang L
    Comput Biol Med; 2014 Apr; 47():58-65. PubMed ID: 24555957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial: Hospital charges for pharmaceutical services.
    Zellmer WA
    Am J Hosp Pharm; 1974 Nov; 31(11):1043. PubMed ID: 4432851
    [No Abstract]   [Full Text] [Related]  

  • 38. The cost of medicine.
    Silk AD
    West J Med; 1990 Jan; 152(1):75-6. PubMed ID: 2309481
    [No Abstract]   [Full Text] [Related]  

  • 39. The Cost of Costing Treatments Incorrectly: Errors in the Application of Drug Prices in Economic Evaluation Due to Failing to Account for the Distribution of Patient Weight.
    Hatswell AJ; Porter J; Lee D; Hertel N; Latimer NR
    Value Health; 2016 Dec; 19(8):1055-1058. PubMed ID: 27987632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differences in costs to hospitals and prices to patients for pharmaceutical products and services.
    Gillies RW; Winship HW
    Hosp Formul; 1976 Apr; 11(4):189-91, 195-8. PubMed ID: 1026683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.